Steward Partners Investment Advisory’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Buy
20,582
+1,547
+8% +$20.4K ﹤0.01% 2000
2026
Q1
$262K Sell
19,035
-7,248
-28% -$109K ﹤0.01% 1877
2025
Q4
$474K Sell
26,283
-775
-3% -$13.9K ﹤0.01% 1459
2025
Q3
$501K Buy
27,058
+12,900
+91% +$203K ﹤0.01% 1374
2025
Q2
$227K Buy
14,158
+440
+3% +$7.84K ﹤0.01% 1701
2025
Q1
$267K Buy
13,718
+128
+0.9% +$2.69K ﹤0.01% 1507
2024
Q4
$299K Buy
13,590
+1,463
+12% +$28.2K ﹤0.01% 1409
2024
Q3
$204K Buy
12,127
+567
+5% +$8.41K ﹤0.01% 1524
2024
Q2
$138K Sell
11,560
-1,263
-10% -$14.1K ﹤0.01% 1628
2024
Q1
$142K Buy
12,823
+2,356
+23% +$24K ﹤0.01% 1591
2023
Q4
$90.6K Buy
10,467
+514
+5% +$4K ﹤0.01% 1738
2023
Q3
$76.1K Buy
9,953
+265
+3% +$1.99K ﹤0.01% 1708
2023
Q2
$69.8K Buy
9,688
+1,052
+12% +$6.13K ﹤0.01% 1745
2023
Q1
$52.6K Buy
8,636
+852
+11% +$4.62K ﹤0.01% 1845
2022
Q4
$33.9K Buy
7,784
+3,494
+81% +$15.6K ﹤0.01% 1988
2022
Q3
$17K Buy
4,290
+3,730
+666% +$18.7K ﹤0.01% 2284
2022
Q2
$3K Buy
+560
New +$2.91K ﹤0.01% 2898

Other funds holding CLBT

Steward Partners Investment Advisory's CLBT Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Cellebrite (CLBT) stake by 8.1% in Q2 2026, buying an estimated $20.4K and bringing the position to 20,582 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

Steward Partners Investment Advisory first reported a position in CLBT in Q2 2022 and has held it in 17 quarters since. The position peaked at $501K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Steward Partners Investment Advisory held 20,582 shares of Cellebrite worth $300K as of Q2 2026.
  • Steward Partners Investment Advisory bought 1,547 Cellebrite shares in Q2 2026, an estimated $20.4K.
  • Cellebrite made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2000 holding.
  • Steward Partners Investment Advisory first reported a position in Cellebrite in Q2 2022 and has held it in 17 quarters since.
  • Steward Partners Investment Advisory's Cellebrite position peaked at $501K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.